Polypharmacy: 5 Key Risks And Management Strategies

Polypharmacy, the concurrent use of multiple medications, is increasingly common among older adults managing chronic conditions, but it heightens risks of adverse drug events, reduced adherence, and poor health outcomes.

What is polypharmacy?

Polypharmacy refers to the regular use of five or more medications, often to treat multiple chronic diseases in seniors, though definitions vary and no universal consensus exists on the exact threshold. This phenomenon arises as patients age and accumulate conditions like diabetes, heart disease, and respiratory issues, leading to prescriptions of six to nine drugs per national guidelines. Problematic polypharmacy occurs when medications are unnecessary, ineffective, duplicative, or inappropriate, necessitating clinical review. Even fewer than five drugs can pose risks if they include high-risk agents like certain sedatives or anticoagulants.

In elderly populations, polypharmacy is a public health concern because older adults comprise 14% of the U.S. population yet account for over one-third of prescription spending, with numbers projected to double by 2060. Factors like frailty, cognitive decline, and multimorbidity drive this trend, making medication optimization essential in geriatric care.

How common is polypharmacy?

Polypharmacy affects a significant portion of seniors across care settings. In outpatient ambulatory care, it is often defined as five or more medications, easily exceeded by patients with two or more chronic conditions. Among hospitalized elderly, 41.4% take 5-8 drugs and 37.2% take nine or more at discharge, with 58.6% on at least one unnecessary medication. In U.S. nursing homes, 39.7% of residents take nine or more drugs per 2004 data, though rates are lower (34.8%) in those aged 85+. Long-term care facilities report up to 91% of patients on five or more daily medications due to frailty and multiple issues. Hospitalized elderly show 20-60% prevalence, varying by study criteria. Overall, older adults with subspecialists but no primary care physician are particularly vulnerable.

Risks and complications of polypharmacy

Polypharmacy elevates risks of adverse drug reactions (ADRs), interactions, non-adherence, falls, fractures, frailty, cognitive dysfunction, malnutrition, hospitalization, disability, institutionalization, and mortality. ADRs cause thousands of elderly injuries or deaths annually, often preventable. Nutritional impacts include reduced fiber, vitamins, and minerals intake alongside higher cholesterol, glucose, and sodium. Non-compliance rates reach 25-75%, worsening with more drugs, age-related impairments, depression, and isolation. High-risk medications amplify dangers even in smaller regimens.

Key risks include:

• Adverse drug events: Direct effects or interactions, responsible for severe outcomes.
• Falls and fractures: Linked to sedatives, antihypertensives, and others affecting balance.
• Cognitive impairment and frailty: Exacerbated by anticholinergics and polypharmacy burden.
• Hospital readmissions: Up to 30% of cases tied to medication issues.
• Increased healthcare costs: From complications and overprescribing.

Causes of polypharmacy

Primary drivers include multimorbidity, where chronic diseases necessitate multiple therapies per guidelines. Older adults often see multiple specialists without coordinated primary care, leading to fragmented prescribing. Long-term care residents face heightened exposure due to frailty and cognitive issues. Age-related changes in pharmacokinetics—slower metabolism, renal impairment—increase ADR susceptibility. Therapeutic duplication, inappropriate indications, and failure to deprescribe outdated drugs compound the issue.

Managing polypharmacy

Effective management requires interprofessional collaboration among physicians, nurses, pharmacists, and patients to optimize regimens. Key strategies include:

• Regular medication reconciliation at transitions of care.
• Linking each drug to a specific indication and reviewing efficacy.
• Prioritizing high-risk medication avoidance (e.g., Beers Criteria lists).
• Patient education on regimens to boost adherence.
• Technology like electronic health records for interaction checks.

Healthcare providers play pivotal roles: pharmacists flag inappropriate drugs (e.g., metformin in renal failure), nurses monitor adherence, and teams balance benefits versus risks.

Deprescribing

Deprescribing—systematically reducing or stopping unnecessary medications—is crucial to mitigate polypharmacy while avoiding underprescribing effective therapies. It involves prioritizing drugs by risk-benefit analysis, starting with those of lowest benefit or highest harm. Tools like Beers Criteria guide identification of potentially inappropriate medications. Shared decision-making with patients/caregivers ensures feasibility, monitoring for withdrawal effects. Studies show deprescribing is safe and feasible in outpatient and nursing home settings, improving outcomes without rebound harm.

Beers Criteria

The Beers Criteria, developed by the American Geriatrics Society, list potentially inappropriate medications (PIMs) for older adults, advising against drugs like benzodiazepines, certain antidepressants, and proton pump inhibitors long-term due to ADR risks outweighing benefits. Updated regularly, it emphasizes individual assessment but flags high-risk classes associated with falls, delirium, and fractures. Providers should consult these alongside patient-specific factors for deprescribing decisions.

STOPP/START criteria

The STOPP (Screening Tool of Older People’s Prescriptions)/START (Screening Tool to Alert to Right Treatment) criteria provide evidence-based guidelines to detect PIMs (STOPP) and underprescribing (START) in seniors. STOPP identifies 80+ criteria for drugs increasing ADR risk, such as NSAIDs in heart failure. START promotes essential therapies often omitted. Validated in multiple studies, these tools enhance prescribing appropriateness, reducing hospitalizations.

Medication reviews

Comprehensive medication reviews (CMRs) by pharmacists or geriatric teams systematically assess regimens for appropriateness, interactions, adherence, and goals of care alignment. Conducted periodically or at care transitions, they involve patient interviews, record reviews, and recommendations for adjustments. In nursing homes and hospitals, nurses/pharmacists facilitate by tracking changes and educating. Technology aids by flagging issues automatically.

Understanding your medicines

Seniors and caregivers must actively understand their medications: names, purposes, doses, side effects, and interactions. Use pill organizers, apps, or lists to track; question new prescriptions; report issues promptly. Discuss goals like symptom relief versus longevity to guide deprescribing. Adherence improves with simplification, but never skip without advice.

Further reading

• Geriatric pharmacology guidelines from AGS.
• Deprescribing.org resources for patients.
• NICE guidelines on multimorbidity.

Frequently Asked Questions

What is polypharmacy?

Polypharmacy is typically the use of five or more medications concurrently, common in seniors with chronic conditions, increasing adverse event risks.

Why is polypharmacy a problem for older people?

It raises chances of drug interactions, falls, cognitive decline, and hospitalization due to age-related changes in drug handling.

How can polypharmacy be reduced?

Through deprescribing unnecessary drugs, regular reviews, interprofessional teams, and tools like Beers Criteria.

What are high-risk medications to avoid?

Beers Criteria highlight benzodiazepines, certain opioids, and anticholinergics as risky for falls and delirium in elders.

Who should perform medication reviews?

Pharmacists, geriatricians, and primary care teams, involving patient input for best outcomes.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb